Advertisements



Volume Growth Drives Railroads in Q3; What Lies Ahead?

Railroads are being aided by the improvement in the coal-.....»»

Category: topSource: zacksNov 14th, 2017

Volume Growth Drives Railroads in Q3; What Lies Ahead?

Railroads are being aided by the improvement in the coal-.....»»

Category: topSource: zacksNov 14th, 2017

Hindustan Unilever beats estimates; profit up 28% at Rs 13.26 bn in Q3

Underlying volume growth came in at 11% for the quarter, ahead of a 6-10% range given by most analysts.....»»

Category: topSource: business-standard36 min. ago

Hindustan Unilever Q3 profit up 28% at Rs 13.26 bn, beats estimates

Underlying volume growth came in at 11% for the quarter, ahead of a 6-10% range given by most analysts.....»»

Category: topSource: business-standard2 hr. 35 min. ago

Hindustan Unilever Q3 net jumps 28% at Rs 13.26 bn, beats estimates

Underlying volume growth came in at 11% for the quarter, ahead of a 6-10% range given by most analysts.....»»

Category: topSource: business-standard3 hr. 5 min. ago

What Lies Ahead For Singapore ETFs?

Singapore's GDP growth slows in Q4 on weaker manufacturing; overall 2017 picture still robust. Singapore’s economic growth slowed in the fourth quarter as the manufacturing secto.....»»

Category: personnelSource: nytJan 2nd, 2018

Rallis India: Market share gains ahead

The Rallis India stock had moved up nine per cent last week on expectations of market share gains led by strong volume growth and product launches. A further traction in contract manufacturing and research with commercialisatio.....»»

Category: topSource: business-standardDec 22nd, 2017

Page Industries: Volume recovery ahead

While GST-led disruption led to muted growth in Q2, expect volumes to bounce back, led by market share gains.....»»

Category: topSource: business-standardDec 19th, 2017

Volume recovery ahead for Page Industries

While GST-led disruption led to muted growth in Q2, expect volumes to bounce back, led by market share gains.....»»

Category: topSource: business-standardDec 19th, 2017

What Lies Ahead for Large-Cap Growth ETFs?

Zacks.....»»

Category: topSource: redinewsDec 14th, 2017

What Lies Ahead for Large-Cap Growth ETFs?

Large-cap growth ETFs are attracting attention, owing to global economic growth. U.S. equities have been rallying lately on strong global growth .....»»

Category: smallbizSource: nytDec 14th, 2017

What Lies Ahead for Tech ETFs?

Wall Street volume low ahead of holiday; tech stocks advance. Trading volumes are low this week, as no major company is scheduled to report earnings. Also, no major economic data release is scheduled. Moreover, markets will remain closed for Th.....»»

Category: topSource: zacksNov 21st, 2017

What Lies Ahead for Hong Kong ETFs?

GDP growth slows in Hong Kong, but support from a global uptick. GDP growth slowed in Hong Kong in the.....»»

Category: topSource: zacksNov 14th, 2017

FMC Corp (FMC) Earnings Beat in Q3, Raises FY17 Outlook

Strong volume and revenue growth at the Lithium unit drives FMC Corp's (FMC) third-quarter 2017 results. .....»»

Category: smallbizSource: nytNov 7th, 2017

What Lies Ahead for South Korea ETFs?

South Korea registers seven-year high GDP growth. South Korea&rsq.....»»

Category: dealsSource: nytOct 31st, 2017

What Lies Ahead for Canada ETFs?

Canada's GDP growth stalls in July, dimming prospects of an immediate rate rise. Canada’s GDP growth was flat month over month in July comp.....»»

Category: worldSource: nytOct 3rd, 2017

Despite Q1 miss, multiple triggers ahead for Maruti

Maruti Suzuki's June quarter (Q1) performance was lower than the Street's expectations across all parameters. While volume growth at 13.2 per cent year-on-year (y-o-y) remained strong, growth in realisations or average selling price.....»»

Category: topSource: business-standardJul 27th, 2017

A Decade Of Sales Growth Lies Ahead For Vertex Pharmaceuticals

Following strong Phase I and II data on Tuesday from three different triple combo regimens for cystic fibrosis, shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) rocketed 30 percent Wednesday to $162.07. Latest Ratings f.....»»

Category: blogSource: benzingaJul 19th, 2017

Street picks Aurobindo Pharma ahead of larger peers on injectibles business

Aurobindo Pharma is among the few companies which are confident about growth in the US market. The company believes that new launches and higher volume will drive growth in US, despite pricing pressure witnessed in the US base busin.....»»

Category: topSource: business-standardMay 31st, 2017

Strong first-quarter earnings are more than a just a rebound

U.S. corporate earnings revisions and our gauge of analyst sentiment have rebounded strongly, as the chart below shows. We believe a catch up in management sentiment lies ahead as earnings growth persists.....»»

Category: topSource: businessinsiderMay 10th, 2017

CSX Posts Stellar Q1 Earnings: What"s Ahead for Railroads?

Apart from better coal volumes, efforts of railroads to control costs are also likely to drive bottom-line growth. .....»»

Category: topSource: zacksApr 24th, 2017